期刊文献+

垂体生长激素腺瘤经蝶手术预后的影响因素分析

Analysis of factors related to prognoses in patients with growth hormone-secreting pituitary adenomas after transsphenoidal surgery
下载PDF
导出
摘要 目的探讨垂体生长激素(GH)腺瘤经蝶手术预后的影响因素。方法回顾性分析60例经蝶手术治疗垂体GH腺瘤患者的临床资料,术后缓解标准为血清IGF-1水平在年龄校正后的正常范围,以及随机血清GH水平<1.0μg/L或OGTT-GH谷值<0.4μg/L。结果术后总缓解率为60%(36/60)。微腺瘤术后缓解率(90.0%)明显高于大腺瘤(46.0%;P<0.05),非侵袭性腺瘤术后缓解率(73.2%)明显高于侵袭性腺瘤(31.6%;P<0.05),术前血清GH≤30μg/L患者术后缓解率(72.5%)明显高于术前血清GH>30μg/L患者(35.0%;P<0.05)。术后缓解患者术后1 d血清GH水平明显低于未缓解患者(P<0.05),根据受试者工作特征(ROC)曲线,术前血清GH水平>1.16μg/L时,判断术后不缓解的敏感度为80.6%,特异度为100%。术后缓解患者术中GH下降程度明显低于未缓解患者(P<0.05),根据ROC曲线,术中血清GH水平下降程度<40%时,判断术后不缓解的敏感度为79.4%,特异度为61.9%。结论术前GH水平>30μg/L、大腺瘤、侵袭性腺瘤是垂体GH腺瘤术后缓解的不良因素;术后1 d血清GH水平<1.16μg/L对术后缓解具有良好的预测效果;术中血清GH下降程度>40%对术后缓解具有一定的预测效果。 ObjectiveTo investigate factors affecting postoperative remission in patients with growth hormone(GH)-secretingpituitary adenomas.MethodsThe clinical data of 60 patients with acromegaly, who underwent transsphenoid surgery in our center wereanalyzed retrospectively. The factors related to the postoperative remission were analyzed by the Cox proportional hazards model.Results Of 60 patients with GH-secreting pituitary adenomas, 36 received postoperative biochemical remission and 24 not. The remission rate(90.0%, 9/10) was significantly higher in the patients with microadenomas than that(46.0%, 23/50) in the patients with macroadenomas(P〈0.05). The remission rate(73.2%, 30/41) was significantly higher in the patients with non-invasive adenomas than that(31.6%, 6/19)in the patients with invasive adenomas(P〈0.05). The remission rate(72.5%, 29/40) was significantly higher in the patients with pre-operative serum GH level ≤30 μg/L than that(35.0%, 7/20) in the patients with preoperative serum GH level 30 μg/L(P〈0.05). Coxproportional hazards model showed that the size and invasiveness of the adenomas, preoperative serum GH level were the factorsaffecting the postoperative remission. The rate of decrease in the serum GH level was significantly lower in the postoperative remissionpatients than that in the patients without postoperative remission immediately after the removal of the adenomas(P〈0.05). The serum GHlevel was significantly lower in the postoperative remission patients than that in the patients without postoperative remission 1 day afterthe surgery.ConclusionHigher preoperative GH levels, marcroadenomas and invasive adenomas suggest the bad prognoses in thepatients with GH-secreting pituitary adenomas. The rate of decrease in the serum GH levels immediately after the removal of theadenomas and the serum GH level 1 day after the surgery may be helpful to predicting the prognoses in the patients with GH-secretingpituitary adenomas.
出处 《中国临床神经外科杂志》 2015年第10期584-587,共4页 Chinese Journal of Clinical Neurosurgery
关键词 肢端肥大症 生长激素腺瘤 经蝶手术 缓解 影响因素 Acromegaly Growth hormone-secreting pituitary adenoma Transsphenoid surgery Remission Factor
  • 相关文献

参考文献21

  • 1Holdaway IM, Rajasoorya C. Epidemiology of acromegaly [J]. Pituitary, 1999, 2(1): 29-41.
  • 2Holdaway IM, Bolland M J, Gamble GD. A meta-analysis of the effect of lowering serum levels of GH and IGF-1 on mortality in acromegaly [J]. Eur J Endocrinol, 2008, 159(2): 89-95.
  • 3Dekkers, OM, Biermasz, NR, Pereira AM, et al. Mortality in acromegaly: a metaanalysis [J]. J Clin Endocrinol Metab, 2008, 93(1):61-67.
  • 4Knosp E, Steiner E, Kitz K, et al. Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings [J]. Neurosurgery, 1993, 33(4): 610-618.
  • 5Wilson CB. Neurosurgical Management of Large and Inva- sive Pituitary Tumors [M]. Clinical Management of Pituitary Disorders. New York: Raven Press, 1979. 335-342.
  • 6Giustina A, Barkan A, Casanueva FF, et al. Criteria for cure of acromegaly: a consensus statement [J]. J Clin Endocrinol Metab, 2000, 85(2): 526-529.
  • 7Melmed S, Casanueva FF, Cavagnini, F, et al. Guidelines for aeromegaly management [J]. J Clin Endocrinol Metab, 2002, 87(9): 4054-4058.
  • 8Giustina A, Chanson P, Bronstein MD, et al. A consensus on criteria for cure of aeromegaly [J]. J Clin Endocrinol Metab, 2010, 95(7), 3141-3148.
  • 9Marquez Y, Tuchman A, Zada G. Surgery and radiosurgery for acromegaly: a review of indications, operative techni- ques, outcomes, and complications [J]. Intern J Endocrinol, 2012, 2012: 386401.
  • 10Zhao B, Wei YK, Li GL, et al. Extended transsphenoidal approaeh for pituitary adenomas invading the anterior cranial base, cavernous sinus, and clivus: a single-center experience with 126 consecutive cases [J]. J Neurosurg, 2010, 112(1): 108-117.

二级参考文献12

  • 1Holdaway IM, Rajasoorya C. Epidemiology of acromegaly [ J ]. Pituitary, 1999, 2(1) : 29 -41.
  • 2Cottier JP, Destrieux C, Brunereau L, et al. Cavernous sinus invasion by pituitary adenomas: MR Imaging [ J]. Radiology, 2000, 215 (2) : 463 - 469.
  • 3Vieira JO Jr, Cukiert A, Liberman B. Evaluation of magnetic resonance imaging criteria for cavernous sinus invasion in patients with pituitary adenomas: logistic regression analysis and correlation with surgical findings [J]. Surg Neurol, 2006, 65(2) : 130 -135.
  • 4Roelfsema F, de Boer H, Frolich M. The influence of octreotide treatment on pulsatile growth hormone release in acromegaly [ J]. Clin Endocrinol (Oxf), 1990, 33(2): 297-306.
  • 5Costa AC, Rossi A, Martinelli CE Jr, et al. Assessment of disease activity in treated acromegalic patients using a sensitive GH assay: should we achieve strict normal GH levels for a biochemical cure [ J ]. J Clin Endocrinol Metab, 2002, 87 (7) : 3142 - 3147.
  • 6Abe T, Ltidecke DK. Recent primary transnasal surgical outcomes associated with intraoperative growth hormone measurement in acromegaly [J]. Clin Endocrinol (Oxf), 1999, 50 ( 1 ) : 27 -35.
  • 7Ludecke DK, Abe T. Transsphenoidal microsurgery for newly diagnosed acromegaly: a personal view after more than 1, 000 operations [ J ]. Neuroendocrinology, 2006, 83 ( 3 - 4 ) : 230 - 239.
  • 8van den Berg G, van Dulken H, Frfilich M, et al. Can intra-operative GH measurement in acromegalic subjects predict completeness of surgery [ J ]. Clin Endocrinol (Oxf) , 1998, 49 ( 1 ) : 45 - 51.
  • 9Shimon I, Cohen ZR, Ram Z, et al. Transsphenoidal surgery for aeromegaly: endocrinological follow-up of 98 patients [ J ]. Neurosurgery, 2001, 48(6) : 1239 - 1245.
  • 10Minniti G, Jaffrain-Rea ML, Esposito V, et al. Evolving criteria for postoperative biochemical remission of acromegaly: can we achieve a definitive cure? An audit of surgical results on a large series and a review of the literature [ J]. Endocr Relat Cancer, 2003, 10 (4): 611 -619.

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部